Key result
Surgical removal of a rare tricuspid valve papillary fibroelastoma (incidence 1/10,000 cardiac surgeries) was successfully performed in a 69-year-old patient with an uneventful postoperative course.
Why the study?
Papillary fibroelastoma represents only 16% of benign cardiac tumors, with approximately 15% located on the tricuspid valve.
Case Report (n=1)
No
Tricuspid valve papillary fibroelastomas are extremely rare (1/10,000 cardiac surgeries) but can be safely managed with surgical excision to prevent embolic events.
Surgical excision of tricuspid valve PFE appears feasible; single case report leaves open natural history and management guidelines.
BACKGROUND AND AIM: Papillary fibroelastoma (PFE) represents only 16% of the benign cardiac tumor and approximately 15% of these are located on the tricuspid valve. MATERIALS AND METHODS: Over a period of 22 years (1999-2021) we observed 75 pts with cardiac tumors at our Center over 9650 pts operated on but only one case of a tricuspid valve PFE in a 69-year-old patient. Trans-thoracic echocardiography demonstrated a mobile mass (20 × 10 mm), adhering to the atrial side of the septal leaflet of the tricuspid valve of unknown origin. In consideration of the mobility of the mass and the consequent high embolic risk, surgical removal was made. The patient underwent surgery through a median sternotomy on CPBP. A 'gelatinous' mass adhering to the tricuspid leaflet was found and completely removed. The postoperative course was uneventful. The pathological diagnosis was PFE. CONCLUSIONS: PFEs of the tricuspid valve are rare entities being in most cases found incidentally. In our experience, the incidence of this tumor in this location is 1/10,000 cases of cardiac surgery. Although most patients are asymptomatic, surgical treatment is nevertheless recommended in consideration of the high embolic risk.
No takes yet. Share an insight, caveat, or question.
Dato et al. (2022) conducted a case report in Tricuspid valve papillary fibroelastoma (n=1). Surgical removal was evaluated on Surgical outcome and tumor incidence. Surgical removal of a rare tricuspid valve papillary fibroelastoma (incidence 1/10,000 cardiac surgeries) was successfully performed in a 69-year-old patient with an uneventful postoperative course.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: